These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26523670)

  • 1. Nonbiological pharmacotherapies for the treatment of diabetic macular edema.
    Agarwal A; Parriott J; Demirel S; Argo C; Sepah YJ; Do DV; Nguyen QD
    Expert Opin Pharmacother; 2015; 16(17):2625-35. PubMed ID: 26523670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy.
    Hussain RM; Ciulla TA
    Expert Opin Biol Ther; 2016; 16(3):365-74. PubMed ID: 26674182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and Future Pharmacologic Therapies for Diabetic Retinopathy.
    Villegas VM; Schwartz SG
    Curr Pharm Des; 2018; 24(41):4903-4910. PubMed ID: 30706803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
    Emerson MV; Lauer AK
    BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Macular Edema: Current Understanding, Pharmacologic Treatment Options, and Developing Therapies.
    Miller K; Fortun JA
    Asia Pac J Ophthalmol (Phila); 2018; 7(1):28-35. PubMed ID: 29473719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging pharmacotherapies for diabetic macular edema.
    Furlani BA; Meyer CH; Rodrigues EB; Maia M; Farah ME; Penha FM; Holz FG
    Expert Opin Emerg Drugs; 2007 Nov; 12(4):591-603. PubMed ID: 17979601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of aflibercept and conbercept in diabetic macular edema.
    Cai S; Yang Q; Li X; Zhang Y
    Drug Des Devel Ther; 2018; 12():3471-3483. PubMed ID: 30410308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for diabetic macular edema.
    Schwartz SG; Flynn HW; Scott IU
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):397-405. PubMed ID: 25141904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Therapies in Development for Diabetic Macular Edema.
    Agarwal A; Afridi R; Hassan M; Sadiq MA; Sepah YJ; Do DV; Nguyen QD
    Curr Diab Rep; 2015 Oct; 15(10):75. PubMed ID: 26294336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upcoming therapeutic advances in diabetic macular edema: an intravitreal dexamethasone drug delivery system.
    Augustin AJ
    Expert Opin Drug Deliv; 2011 Feb; 8(2):271-9. PubMed ID: 21222552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates on the Clinical Trials in Diabetic Macular Edema.
    Demirel S; Argo C; Agarwal A; Parriott J; Sepah YJ; Do DV; Nguyen QD
    Middle East Afr J Ophthalmol; 2016; 23(1):3-12. PubMed ID: 26957834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological treatment for diabetic macular edema].
    Fukumoto M; Ikeda T
    Nihon Rinsho; 2015 Mar; 73(3):484-8. PubMed ID: 25812378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What have we learnt about the management of diabetic macular edema in the antivascular endothelial growth factor and corticosteroid era?
    Agarwal A; Sarwar S; Sepah YJ; Nguyen QD
    Curr Opin Ophthalmol; 2015 May; 26(3):177-83. PubMed ID: 25784111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.
    Silva PS; Sun JK; Aiello LP
    Semin Ophthalmol; 2009; 24(2):93-9. PubMed ID: 19373693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment of macular edema].
    Conrath J
    J Fr Ophtalmol; 2007 Sep; 30(7):748-56. PubMed ID: 17878829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
    Morjaria R; Chong NV
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1185-92. PubMed ID: 24856361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on nonsurgical therapy for diabetic macular edema.
    Witkin AJ; Brown GC
    Curr Opin Ophthalmol; 2011 May; 22(3):185-9. PubMed ID: 21427573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment.
    Bhatwadekar AD; Kansara VS; Ciulla TA
    Expert Opin Investig Drugs; 2020 Mar; 29(3):237-244. PubMed ID: 31985300
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetic macular edema.
    Lang GE
    Ophthalmologica; 2012; 227 Suppl 1():21-9. PubMed ID: 22517122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology.
    Ho AC; Scott IU; Kim SJ; Brown GC; Brown MM; Ip MS; Recchia FM
    Ophthalmology; 2012 Oct; 119(10):2179-88. PubMed ID: 22917890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.